Nissim Hay Selected Research

Acute Myeloid Leukemia (Acute Myelogenous Leukemia)

1/2008

Regulatory effects of mammalian target of rapamycin-mediated signals in the generation of arsenic trioxide responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nissim Hay Research Topics

Disease

33	Neoplasms (Cancer) 01/2022 - 11/2002
7	Carcinogenesis 01/2022 - 10/2006
4	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 02/2015
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2011
3	Breast Neoplasms (Breast Cancer) 01/2022 - 07/2013
3	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 03/2010
3	Leukemia 01/2018 - 02/2005
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 06/2009
2	Inflammation (Inflammations) 10/2016 - 04/2014
2	Acute Promyelocytic Leukemia 04/2008 - 02/2005
2	Hypoxia (Hypoxemia) 04/2005 - 02/2004
1	Melanoma (Melanoma, Malignant) 01/2021
1	Rheumatoid Arthritis 11/2018
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2018
1	T-Cell Leukemia (Leukemia, T Cell) 01/2018
1	Virus Diseases (Viral Diseases) 01/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018
1	Diabetes Mellitus 01/2018
1	Communicable Diseases (Infectious Diseases) 01/2018
1	Atrophy 03/2016
1	Sickle Cell Anemia (Hemoglobin S Disease) 04/2014
1	Lung Neoplasms (Lung Cancer) 08/2013
1	Atherosclerosis 06/2012
1	Glioma (Gliomas) 06/2011
1	Astrocytoma (Pilocytic Astrocytoma) 06/2011
1	Insulin Resistance 06/2009
1	Hyperglycemia 06/2009
1	Renal Cell Carcinoma (Grawitz Tumor) 07/2008
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2008
1	Pathologic Neovascularization 11/2005

Drug/Important Bio-Agent (IBA)

9	Protein Isoforms (Isoforms)IBA 10/2020 - 11/2005
8	Phosphotransferases (Kinase)IBA 01/2022 - 04/2005
7	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2009
7	HexokinaseIBA 01/2022 - 08/2013
4	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2018 - 11/2002
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 07/2013
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 04/2014 - 02/2009
3	TOR Serine-Threonine KinasesIBA 03/2012 - 01/2008
3	Eukaryotic Initiation Factor-4EIBA 08/2010 - 02/2005
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2014
2	Insulin (Novolin)FDA Link 10/2020 - 01/2018
2	GlucokinaseIBA 01/2018 - 02/2015
2	Sirolimus (Rapamycin)FDA Link 01/2018 - 12/2008
2	Metformin (Glucophage)FDA LinkGeneric 01/2018 - 01/2018
2	EnzymesIBA 01/2018 - 07/2013
2	Adenosine Triphosphate (ATP)IBA 10/2012 - 05/2012
2	NADP (NADPH)IBA 10/2012 - 05/2012
2	Mechanistic Target of Rapamycin Complex 1IBA 03/2012 - 10/2006
2	Transcription Factors (Transcription Factor)IBA 01/2011 - 10/2009
2	Biological ProductsIBA 03/2010 - 02/2005
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Calcium-Binding ProteinsIBA 01/2021
1	Messenger RNA (mRNA)IBA 10/2020
1	Superoxides (Superoxide)IBA 01/2018
1	Copper-Transporting ATPasesIBA 01/2018
1	AntioxidantsIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Superoxide DismutaseIBA 01/2018
1	Copper Transport ProteinsIBA 01/2018
1	Sorafenib (BAY 43-9006)FDA Link 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2016
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 04/2016
1	Retinaldehyde (Retinal)IBA 03/2016
1	MitogensIBA 02/2014
1	Small Interfering RNA (siRNA)IBA 09/2013
1	Cadherins (E-Cadherin)IBA 09/2013
1	CarbonIBA 08/2013
1	RibonucleotidesIBA 08/2013
1	Glutamine (L-Glutamine)FDA Link 08/2013
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 07/2013
1	phenethyl isothiocyanate (PEITC)IBA 07/2013
1	Bortezomib (Velcade)FDA Link 07/2013
1	Proteasome InhibitorsIBA 07/2013
1	Cholesterol Esters (Cholesteryl Esters)IBA 06/2012
1	epidermal growth factor receptor VIIIIBA 06/2011
1	Peptides (Polypeptides)IBA 01/2011
1	StathminIBA 01/2011
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2011
1	Oncogene Proteins (Oncogene Protein)IBA 07/2010
1	LigandsIBA 03/2010
1	Jagged-1 ProteinIBA 03/2010
1	NF-kappa B (NF-kB)IBA 03/2010
1	LeptinIBA 06/2009
1	Protein Kinases (Protein Kinase)IBA 02/2009
1	Etoposide (VP 16)FDA LinkGeneric 12/2008
1	Cytostatic AgentsIBA 12/2008
1	Fluvastatin FDA Link 07/2008
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2008
1	Peptide Initiation Factors (Initiation Factor)IBA 04/2008
1	Arsenic Trioxide (Trisenox)FDA Link 01/2008
1	Aligeron (AS 2)IBA 01/2008
1	Cyclin D1IBA 05/2007
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 02/2005
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 02/2005
1	Oxygen (Dioxygen)IBA 02/2004

Therapy/Procedure

12	Therapeutics 01/2018 - 09/2005
1	Aftercare (After-Treatment) 07/2013
1	Transplantation 06/2011